Clinical Trial Update: Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa [Phase 3]

View source ↗

Summary

This clinical trial update notes that a Phase 3 study of KW-6002 (istradefylline) in Parkinson's disease patients with motor fluctuations on levodopa has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• KW-6002 (istradefylline) (istradefylline)

Snippet

Sponsor: University of Chicago | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED